MALAT1 and cancer: Like MALAT1, STAT3 dysregulation is not unique to ES due to its many roles in proliferation, migration, angiogenesis and microenvironment conditions in a variety cancers, and it is a popular target for a multitude of pharmaceutical inhibitors [36].